Skip to content

Welcome to the new Aloha Fungi shop!Have a question or an idea? Message us on WhatsApp: MattKubaFranek

How does Cordyceps work? Five mechanisms explained

Cordyceps contains cordycepin, cordycepic acid and polysaccharides studied for the adenosine axis, mitochondria, HPA and immunity. Mechanism, not a promise.

Mateusz Rosa

TCM therapist · Doctor of Acupuncture (WFAS) · author of a book on functional mushrooms

5 min read

How does Cordyceps work? Five mechanisms explained
Contents

Cordyceps is a genus of ascomycete fungi that in nature parasitizes insects and moth larvae. Two species matter in supplementation: Cordyceps militaris (commercially cultivated, higher cordycepin content) and Cordyceps sinensis (now Ophiocordyceps sinensis), the classic fungus of Tibetan medicine and TCM.

This article walks through five mechanisms by which scientific literature and TCM tradition explain the place of Cordyceps in a supplementation ritual. It describes mechanism and research, not a promise of effect for any individual reader.

What bioactive compounds does Cordyceps contain?

The main compounds are cordycepin (3′-deoxyadenosine), cordycepic acid (D-mannitol), polysaccharides, ergosterol and adenosine. In TCM tradition, Cordyceps is a kidney (Jing) and lung tonic, classically associated with recovery after prolonged illness and Yang Qi depletion [Shweta et al. 2023].

Cordycepin is an adenosine analog with affinity to A1, A2A, A2B and A3 receptors [Du et al. 2021, DOI: 10.26502/jbb.2642-91280035]. Cordycepic acid is a sugar alcohol with osmotic properties, classically linked to kidney function.

How does the adenosine-ATP axis work?

Adenosine signals a cell's energy state. As ATP is used up, its breakdown generates adenosine, which through A1-A3 receptors acts as a brake regulating heart function, blood vessels and the nervous system. Cordycepin modulates this signal, inhibiting it in some tissues and activating it in others.

This differs from caffeine, which blocks adenosine receptors and acts as an immediate stimulant. Receptor modulation is a regulatory process, not an instant "boost".

What does research say about mitochondrial function?

In animal models, Cordyceps extracts activate AMPK (the cell's energy sensor) and support antioxidant enzyme expression via the Nrf2 pathway [Chen et al. 2023]. This mechanism is largely preclinical, based on animal models and cell cultures, not direct measurements in humans.

Mitochondria produce ATP, the cell's universal energy currency. Chronic fatigue in the literature correlates with reduced mitochondrial efficiency and elevated oxidative stress.

How does Cordyceps relate to the HPA axis and the adaptogen concept?

The hypothalamic-pituitary-adrenal (HPA) axis is the body's main stress-response circuit. Herb-and-mushroom classification calls Cordyceps an adaptogen, a concept describing substances with low toxicity that act non-specifically on regulation rather than on one specific system.

In animal models, Cordyceps modulates cortisol secretion and stress-response patterns. TCM literature describes the same phenomenon as a "Jing tonic", a deep reservoir of kidney energy tied to constitutional vitality.

What does research show about immune effects?

Cordyceps contains beta-glucans and other polysaccharides recognized by pattern-recognition receptors (Dectin-1, CR3, TLR2/4) on immune cells. Read more about this mechanism in our article on beta-glucans. The profile observed in animal models is regulatory, not stimulating.

Studies observe macrophage polarization toward the M2 phenotype, modulation of T-helper cell balance, and support for NK cell activity. This sets the described mechanism apart from a "boost immunity" claim: in states of immune overactivity, modulation runs downward, so people with an active autoimmune condition should consult a doctor before supplementing.

What did the Hirsch et al. 2017 study find?

The most frequently cited RCT (randomized, double-blind, placebo-controlled) on Cordyceps is Hirsch et al. 2017: n=28 (phase 1) and n=10 (phase 2), 4 g daily of a mushroom blend containing C. militaris, with an observed VO2max increase of 4.8 ml·kg⁻¹·min⁻¹ after 3 weeks versus placebo (p=0.042).

Limitations: a mushroom blend, not isolated Cordyceps; a small sample (n=10 in the 3-week phase); young, healthy participants not representative of people with burnout or chronic illness. Later work (Dudgeon et al. 2018) reinforces this picture.

Cordyceps militaris or sinensis, what is the difference?

Cordyceps militaris is commercially cultivated and contains significant cordycepin (0.3-1% in fruiting-body extract). Cordyceps sinensis is the classic TCM fungus, described in the 1757 Bencao Congxin, but in nature contains only trace cordycepin, and most commercially available "sinensis" is actually Cs-4 mycelium culture (Paecilomyces hepiali).

In Aloha Fungi's practice we work with C. militaris for source transparency and a better-documented cordycepin content. For the full comparison of both species and a label checklist, see our post Chinese caterpillar fungus vs. Cordyceps militaris.

What does Cordyceps not do?

Cordyceps is not a "natural EPO", does not replace training or medical therapy, and does not act instantly. Our suggested minimum protocol is 90 days of regular use in a 5 days ON / 2 days OFF rhythm, ideally in the morning or at midday, since Cordyceps tends to have a mildly activating profile.

People on immunosuppressive, anticoagulant or antidiabetic medication, who are pregnant, breastfeeding, or have an active autoimmune condition should consult a doctor before supplementing.

What are the properties of cordyceps and what does it help with?

Cordyceps, in Chinese tradition, accompanied people who needed energy and endurance. Today it is the most represented mushroom in our Research Atlas: 18 pieces of literature, including studies with human participants. A food supplement is not for treating disease; what exactly each study checked and with what result, we describe at every entry in the registry, even when the result was weak.

References

  • Hirsch KR, Smith-Ryan AE, Roelofs EJ, Trexler ET, Mock MG. (2017). Cordyceps militaris Improves Tolerance to High-Intensity Exercise After Acute and Chronic Supplementation. Journal of Dietary Supplements, 14(1): 42-53. DOI: 10.1080/19390211.2016.1203386
  • Du J, Kan W, Bao H et al. (2021). Interactions Between Adenosine Receptors and Cordycepin from Cordyceps Militaris. Journal of Biotechnology and Biomedicine, 4: 26-62. DOI: 10.26502/jbb.2642-91280035
  • Chen M, Luo J, Jiang W et al. (2023). Cordycepin: A review of strategies to improve the bioavailability and efficacy. Phytotherapy Research, 37(9): 3839-3858. DOI: 10.1002/ptr.7921
  • Shweta, Abdullah S, Komal, Kumar A. (2023). A brief review on the medicinal uses of Cordyceps militaris. Pharmacological Research - Modern Chinese Medicine, 7: 100228. DOI: 10.1016/j.prmcm.2023.100228

This content is for educational purposes only and does not constitute medical advice. A food supplement does not replace a varied diet or a healthy lifestyle. If in doubt, consult your doctor or pharmacist.

Cordyceps in scientific research

What was studied, on how many people and with what level of evidence. This overview describes studies, not the effects of a product.

9

human studies

3

placebo-controlled RCTs

2000–2026

years of publication

  • Zhou J. et al., 2021

    C

    RCT, double-blind, placebo-controlled

    59 people

    The study examined Cordyceps militaris as an add-on to duloxetine for insomnia associated with depression, in a group of 59 people, using a double-blind, placebo-controlled RCT design.

    PMID 34858228
  • Ontawong A. et al., 2024

    C

    RCT

    40 healthy adults

    The study examined the effect of a Cordyceps militaris beverage on immune response in 40 healthy adults, using an RCT design.

    PMID 38580687
  • Dubhashi S. et al., 2023

    C

    RCT, double-blind, placebo-controlled

    65 enrolled, 58 evaluated

    The study examined Cordyceps militaris in mild-to-moderate COVID-19, using a double-blind, placebo-controlled RCT, with 65 people enrolled (58 evaluated).

    PMID 37727187
  • Yang E.-J. et al., 2026

    E

    narrative review · preclinical studies (in vitro and rodent)

    not applicable

    The narrative review collected in vitro, in vivo and clinical data on Cordyceps militaris.

    PMID 41432716
  • Shu M.-Y. et al., 2025

    B

    systematic review with meta-analysis

    14 RCTs, 528 athletes

    The systematic review with meta-analysis collected 14 RCTs (528 athletes) on functional mushroom supplementation in athletes; the review covers multiple mushroom species at once, not only Cordyceps militaris.

    PMID 41280379
  • Choi E. et al., 2020

    E

    animal study (mice) · preclinical studies (in vitro and rodent)

    not applicable

    The mouse study examined the effect of Cordyceps militaris on physical performance.

    PMID 33312018
  • Hirsch K.R. et al., 2017

    C

    RCT, double-blind, placebo-controlled (mushroom blend, not an isolated species)

    28 (acute phase), 10 (chronic phase)

    The study examined the effect of a mushroom blend containing C. militaris (4 g/day) on VO2max, time to exhaustion, ventilatory threshold and power in a cycle ergometer test, using 1-week and 3-week protocols in trained adults. Limitations: n=10 in the chronic phase, a multi-ingredient preparation not isolating the species.

    PMID 27408987
  • Jędrejko M. et al., 2026

    E

    narrative review of human studies · preclinical studies (in vitro and rodent)

    5 studies, 321 participants aged 16-35

    The narrative review collected 5 intervention studies (2017-2024) on ergogenic effects and post-exercise recovery with supplementation in humans. Small samples, heterogeneous participants and protocols, incomplete randomisation reporting, most studies not registered.

    PMID 41829950
  • Tuli H.S. et al., 2014

    E

    narrative review · preclinical studies (in vitro and rodent)

    not applicable

    The review discussed the pharmacological potential of the genus Cordyceps, with particular focus on cordycepin, based on in vitro/in vivo data.

    DOI 10.1007/s13205-013-0121-9
  • Olatunji O.J. et al., 2018

    E

    narrative review (whole genus Cordyceps) · preclinical studies (in vitro and rodent)

    not applicable

    The review collected traditional uses, phytochemistry and pharmacology of the entire genus Cordyceps without separating species.

    PMID 29775778
  • Du J. et al., 2021

    E

    narrative review · preclinical studies (in vitro and rodent)

    not applicable

    The paper discussed mechanisms of cordycepin interaction with adenosine receptors and hypothetically linked this to brain protection and COVID-19. Purely theoretical, with no original data.

    DOI 10.26502/jbb.2642-91280035
  • Ko K.M., Leung H.Y., 2007

    E

    narrative review · preclinical studies (in vitro and rodent)

    not applicable

    The review discussed TCM tonic herbs (Cordyceps as one of several) in the context of ATP, antioxidation and immunomodulation. Does not isolate Cordyceps.

    PMID 17386115
  • Chen S. et al., 2010

    D

    pilot RCT

    20 enrolled, 15 completed

    The pilot randomised study examined the effect of the Cs-4 preparation (a fermented Cordyceps sinensis product) on physical performance in older adults, 20 enrolled, 15 completed.

    PMID 20804368
  • Parcell A.C. et al., 2004

    C

    RCT, double-blind

    22 cyclists

    The double-blind RCT examined the effect of the CordyMax Cs-4 preparation (Cordyceps sinensis) on performance in 22 cyclists.

    PMID 15118196
  • Yu X. et al., 2019

    B

    systematic review with meta-analysis

    14 RCTs, 1192 people

    The systematic review with meta-analysis collected 14 RCTs (1192 people) on Cordyceps sinensis in stable chronic obstructive pulmonary disease (COPD).

    PMID 31073318
  • Wu F. et al., 2025

    B

    systematic review with meta-analysis of RCTs

    15 RCTs, 1310 people

    The meta-analysis collected RCTs on oral Cordyceps sinensis as adjunct therapy in patients with renal dysfunction (creatinine, oliguria duration, urine osmolality). Small samples, short observation periods, predominance of studies from China.

    PMID 39839641
  • Kumar R. et al., 2011

    E

    animal study (rats) · preclinical studies (in vitro and rodent)

    not applicable

    The rat study examined exercise endurance capacity and skeletal muscle metabolic regulators after Cordyceps sinensis administration.

    PMID 21549819
  • Chiou W.F. et al., 2000

    E

    animal (rats) + in vitro (aorta) · preclinical studies (in vitro and rodent)

    not applicable

    The study in anaesthetised rats and isolated aortic rings examined the effect of a Cordyceps sinensis protein fraction on arterial pressure (intravenous administration) and vascular relaxation. Animal model, intravenous administration, does not translate to an oral supplement.

    PMID 10755473

Evidence levels: A · Cochrane review · B · systematic review · C · placebo RCT · D · pilot RCT · E · preclinical studies

What these studies don't say

  • Samples are usually small, most from a single population.
  • Results describe research interventions, not a dietary supplement.
  • The presence of a study is not a health claim.

Source: Aloha Fungi literature review, 1 September 2026; entries verified via PubMed or by DOI (Crossref). See the research

Discover functional mushrooms

© 2026 Aloha Fungi™